Santaris Pharma A/S's Experimental Drug Is Combating Hepatitis C In Chimps, Southwest Foundation For Biomedical Research Researchers Say
ScienceDaily (Dec. 3, 2009) — In a dramatic finding, a new drug for hepatitis C virus (HCV) infections that targets liver cells produced a substantial drop in blood levels of the virus in animals and continued to work up to several months after treatment, say scientists at the Southwest Foundation for Biomedical Research (SFBR) in San Antonio.